IL188521A0 - Compositions and methods for protein deaggregation - Google Patents
Compositions and methods for protein deaggregationInfo
- Publication number
- IL188521A0 IL188521A0 IL188521A IL18852107A IL188521A0 IL 188521 A0 IL188521 A0 IL 188521A0 IL 188521 A IL188521 A IL 188521A IL 18852107 A IL18852107 A IL 18852107A IL 188521 A0 IL188521 A0 IL 188521A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- protein deaggregation
- deaggregation
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70254505P | 2005-07-25 | 2005-07-25 | |
PCT/US2006/028706 WO2007014170A2 (en) | 2005-07-25 | 2006-07-24 | Compositions and methods for protein deaggregation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL188521A0 true IL188521A0 (en) | 2008-04-13 |
Family
ID=37683892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL188521A IL188521A0 (en) | 2005-07-25 | 2007-12-31 | Compositions and methods for protein deaggregation |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070021591A1 (pt) |
EP (1) | EP1910415A4 (pt) |
JP (1) | JP2009504571A (pt) |
KR (1) | KR20080041640A (pt) |
CN (1) | CN101511858A (pt) |
AU (1) | AU2006272714A1 (pt) |
BR (1) | BRPI0613653A2 (pt) |
CA (1) | CA2614082A1 (pt) |
IL (1) | IL188521A0 (pt) |
WO (1) | WO2007014170A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2779850C (en) * | 2011-06-17 | 2016-08-09 | Norgen Biotek Corporation | Methods, reagents and kits for preservation of nucleic acids in biological samples |
JP6159724B2 (ja) * | 2011-08-23 | 2017-07-05 | ロシュ グリクアート アーゲー | T細胞活性化抗原に対して特異的な二重特異性抗体及び腫瘍抗原および使用方法 |
CN103609714B (zh) * | 2013-12-02 | 2014-10-15 | 北京市京广禾生物科技有限公司 | 一种植物基乳粉的生产方法 |
MA41645A (fr) * | 2015-03-04 | 2018-01-09 | Abbvie Stemcentrx Llc | Anticorps issus de génie génétique spécifiques au site et méthodes d'utilisation |
GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
CN109153992B (zh) | 2016-05-27 | 2022-11-29 | 诺根生物科技公司 | 生物样本中游离核酸的保存 |
US11680948B2 (en) | 2016-08-12 | 2023-06-20 | Abreos Biosciences, Inc. | Detection and quantification of natalizumab |
EP3606937A4 (en) * | 2017-04-04 | 2020-12-30 | Abreos Biosciences, Inc. | IMMUNOAFFINITY PURIFICATION OF ANTIBODIES USING MIMETOPES |
WO2019217927A1 (en) | 2018-05-10 | 2019-11-14 | Regeneron Pharmaceuticals, Inc. | High concentration vegf receptor fusion protein containing formulations |
CN111965356B (zh) * | 2019-11-28 | 2023-09-08 | 上海荣盛生物药业股份有限公司 | 巯基还原组合物及荧光微球层析试纸和应用 |
CN110954692A (zh) * | 2019-12-20 | 2020-04-03 | 蓝怡科技集团股份有限公司 | 一种还原剂缓冲液及其制备方法和应用 |
CN110987571A (zh) * | 2019-12-31 | 2020-04-10 | 广州金域医学检验中心有限公司 | 一种单克隆多聚体m蛋白解聚方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4599197A (en) * | 1982-12-22 | 1986-07-08 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
GR79124B (pt) * | 1982-12-22 | 1984-10-02 | Genentech Inc | |
US4518526A (en) * | 1982-12-22 | 1985-05-21 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US5340926A (en) * | 1983-03-25 | 1994-08-23 | Celltech, Limited | Process for the recovery of recombinantly produced protein from insoluble aggregate |
US4652630A (en) * | 1985-02-22 | 1987-03-24 | Monsanto Company | Method of somatotropin naturation |
ES8800957A1 (es) * | 1985-02-22 | 1987-12-01 | Monsanto Co | Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina |
US5523215A (en) * | 1985-03-28 | 1996-06-04 | Chiron Corporation | Enhanced purification and expression of insoluble recombinant proteins |
US5162507A (en) * | 1987-05-11 | 1992-11-10 | Cetus Corporation | Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
ES2248818T3 (es) * | 1995-06-07 | 2006-03-16 | Chiron Corporation | Metodo de solubilizacion, purificacion y replegamiento de proteinas. |
JP4239412B2 (ja) * | 1998-12-28 | 2009-03-18 | 味の素株式会社 | トランスグルタミナーゼの製造方法 |
US7615617B2 (en) * | 1999-10-25 | 2009-11-10 | University Of Delaware | Use of hydrostatic pressure to inhibit and reverse protein aggregation and facilitate protein refolding |
MXPA03003867A (es) * | 2000-10-31 | 2004-10-15 | Univ Colorado Regents | Desagregacion mejorada de proteina y replegamiento utilizando alta presion. |
AU2002351353A1 (en) * | 2001-12-19 | 2003-09-02 | Genentech, Inc. | Stabilizing polypeptides which have been exposed to urea |
US6870034B2 (en) * | 2002-02-05 | 2005-03-22 | Genentech, Inc. | Protein purification |
-
2006
- 2006-07-24 BR BRPI0613653-2A patent/BRPI0613653A2/pt not_active Application Discontinuation
- 2006-07-24 AU AU2006272714A patent/AU2006272714A1/en not_active Abandoned
- 2006-07-24 US US11/459,544 patent/US20070021591A1/en not_active Abandoned
- 2006-07-24 CN CNA2006800267092A patent/CN101511858A/zh active Pending
- 2006-07-24 WO PCT/US2006/028706 patent/WO2007014170A2/en active Application Filing
- 2006-07-24 KR KR1020087003038A patent/KR20080041640A/ko not_active Application Discontinuation
- 2006-07-24 EP EP06788329A patent/EP1910415A4/en not_active Withdrawn
- 2006-07-24 CA CA002614082A patent/CA2614082A1/en not_active Abandoned
- 2006-07-24 JP JP2008524031A patent/JP2009504571A/ja active Pending
-
2007
- 2007-12-31 IL IL188521A patent/IL188521A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1910415A4 (en) | 2010-08-11 |
WO2007014170A3 (en) | 2009-04-23 |
KR20080041640A (ko) | 2008-05-13 |
EP1910415A2 (en) | 2008-04-16 |
WO2007014170A2 (en) | 2007-02-01 |
US20070021591A1 (en) | 2007-01-25 |
JP2009504571A (ja) | 2009-02-05 |
CN101511858A (zh) | 2009-08-19 |
AU2006272714A1 (en) | 2007-02-01 |
CA2614082A1 (en) | 2007-02-01 |
BRPI0613653A2 (pt) | 2011-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL188521A0 (en) | Compositions and methods for protein deaggregation | |
PL1940240T3 (pl) | Kompozycje izolatu białka i ich zastosowania | |
IL190259A0 (en) | Compositions and methods comprising panax species | |
EP1895838A4 (en) | COMPOSITIONS AND METHODS | |
GB0522287D0 (en) | Method and compositions | |
EP1889908A4 (en) | PROTEIN FUSED WITH ANTI-CD14 ANTIBODY | |
GB0504767D0 (en) | Lipocalin protein | |
IL187617A0 (en) | Lkktet and/or lkktnt peptide compositions and methods | |
GB0525314D0 (en) | Method and composition | |
HK1104238A1 (en) | Abnormal protein removing composition | |
IL211089A0 (en) | Compositions and methods for cell killing | |
IL191072A0 (en) | Therapeutic compositions and methods | |
ZA200608932B (en) | Method and compositions for epilation | |
EP1962852A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
ZA200803283B (en) | Pharmaceutical gallium compositions and methods | |
ZA200608935B (en) | Methods and compositions for epilation | |
IL189685A0 (en) | Compositions and methods for analyzing protein interactions | |
GB0524927D0 (en) | Compositions and method | |
ZA200805079B (en) | Immunostimulatory compositions and methods | |
ZA200802969B (en) | Composition and method | |
GB0522655D0 (en) | Composition and method | |
GB0501348D0 (en) | Compositions and methods | |
GB0511235D0 (en) | Compositions and method | |
IL182970A0 (en) | Compositions and processes for preparing 13-deoxy-anthracyclines | |
EP1924257A4 (en) | STABILIZED 3-HYDROXYFLAVAN COMPOSITIONS AND METHOD THEREFOR |